Dental implant with excellent antibacterial properties and antibacterial coating method
A silver-titanium oxide matrix coating on dental implants addresses bacterial infections by sustained silver ion release, reducing early failure and enhancing long-term stability.
Patent Information
- Application Number
- JP2024538388
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-29
- Filing Date
- 2022-12-06
- Publication Date
- 2024-12-05
- Estimated Expiration
- 2042-12-06
AI Technical Summary
Dental implants face high early failure rates due to bacterial infections and bone loss, particularly from anaerobic bacteria, which compromise fixation force and stability.
A dental implant with a silver-titanium oxide matrix coating, formed through hydrothermal treatment of a titanium substrate with a silver precursor, providing sustained release of antibacterial silver ions to inhibit biofilm formation and bacterial adhesion.
The coating enhances antibacterial properties, reducing early implant failure and improving long-term stability by maintaining effective antibacterial action for an extended period.
Smart Images

Figure 2024545346000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a dental implant having excellent antibacterial properties and an antibacterial coating method. [Background technology]
[0002] Dental implants are artificial teeth that can permanently replace missing teeth, and are widely used to restore chewing function in partially or completely edentulous areas. Therefore, implants must not only function as real teeth, but also be able to properly distribute the load applied to the teeth and be made to last for a long time.
[0003] To increase the success rate of implants, the stability of the implant, i.e., the fixation force, is determined by the patient's bone volume and bone quality. Implant stability is expressed as the sum of the primary stability that occurs when the implant comes into contact with the surrounding bone, and the secondary stability that is obtained when new bone tissue is formed after the implant is placed and bone adhesion occurs. In particular, improving early stability after implant placement is an important factor in increasing mid- to long-term stability and ultimately the success rate of implants.
[0004] The main cause of early implant failure is loss of bone around the implant or a decrease in fixation strength due to various reasons such as product defects, procedure factors, and patient factors. In particular, when bone around the implant is lost, the fixation strength of the implant inevitably decreases due to the loss. As a result of analyzing early failure cases due to loss of bone around the implant, early failure due to periodontitis or detection of bacteria accounted for approximately 90% of cases, and an analysis of products recalled from customers revealed that anaerobic bacteria was detected in approximately 60% of cases.
[0005] In order to solve these problems, a method has been proposed to build a system that can actively defend against contaminated saliva and bacteria by imparting antibacterial properties to the surface of the implant. In particular, in order to reduce the early failure rate of the implant, the antibacterial properties must be maintained even during the initial implantation period. Therefore, there is a need for research and development of an antibacterial coating method that can impart antibacterial properties to the surface of the implant and maintain the antibacterial properties during the initial implantation period, and a dental implant using the same. Summary of the Invention [Problem to be solved by the invention]
[0006] The present invention provides a dental implant with excellent antibacterial properties and an antibacterial coating method. [Means for solving the problem]
[0007] According to one embodiment, there is provided a dental implant comprising a titanium substrate and a silver-titanium oxide matrix coated on at least a portion of a surface of the substrate, the silver-titanium oxide matrix having a peak P1 with binding energies of 570 to 580 eV and a peak P2 with binding energies of 360 to 375 eV as measured by XPS, and an intensity I1 of P1 and an intensity I2 of P2 satisfying the following formula:
[0008]
number
[0009] In one embodiment, the dental implant may release up to 1 ppm silver per day in an inorganic solvent at 37° C. for at least one week.
[0010] According to another aspect, there is provided a method for antibacterial coating of a dental implant, comprising the steps of (a) supporting a titanium substrate in a coating solution in which a silver precursor is dissolved to have an Ag concentration of 10 to 300 mM, and (b) heating the coating solution to perform a hydrothermal treatment.
[0011] In one embodiment, the silver precursor may be one selected from the group consisting of silver nitrate (AgNO3), silver perchlorate (AgClO4), silver tetrafluoroborate (AgBF4), silver hexafluorophosphate (AgPF6), silver acetate (CH3COOAg), silver trifluoromethanesulfonate (AgCF3SO3), silver sulfate (Ag2SO4), silver 2,4-pentanedionate (CH3COCH=COCH3Ag), silver oxides (AgO, Ag2O, Ag2O2, Ag2O3), and mixtures of two or more thereof.
[0012] In one embodiment, the method may further include a pre-treatment step of treating the titanium substrate by at least one of sandblasting, etching, cleaning, and drying before carrying out step (a).
[0013] In one embodiment, the step (b) may be carried out at 150 to 300° C. for 1 to 5 hours. Effect of the Invention
[0014] According to one aspect, the dental implant and antibacterial coating method with excellent antibacterial properties form a silver-titanium oxide matrix on the surface of the implant, thereby improving the antibacterial properties of the implant. Silver ions are gradually released from the silver-titanium oxide matrix during the initial implantation period, imparting and maintaining the antibacterial properties of the implant. This reduces the early failure rate of the dental implant, ultimately improving the success rate of the implant.
[0015] The effects of one embodiment of this specification are not limited to the effects described above, but should be understood to include all effects that can be inferred from the configurations described in the detailed description of this specification or the claims. [Brief description of the drawings]
[0016] [Figure 1] FIG. 1 is an antibacterial performance evaluation graph for a selection of antibacterial ions of the present specification. [Diagram 2]FIG. 2 is a removal torque graph for a selection of antimicrobial coating methods herein. [Diagram 3] FIG. 3 is a graph showing the antibacterial performance evaluation according to the hydrothermal treatment conditions. [Figure 4] FIG. 4 shows FE-SEM analysis images of the examples and comparative examples of this specification. [Diagram 5] FIG. 5 shows the results of analyzing the SEM image and the position-specific element distribution map of the example of the present specification. [Figure 6] FIG. 6 shows EDS analysis images of the examples and comparative examples of this specification. [Figure 7] FIG. 7 is an XPS analysis graph of the examples and comparative examples of this specification. [Figure 8] FIG. 8 is a graph of Ag release amount for the examples herein. [Figure 9] FIG. 9 is a graph showing the antibacterial performance evaluation according to the supporting period in the examples of the present specification. [Figure 10] FIG. 10 is a graph showing the antibacterial performance evaluation according to the washing conditions of the examples and comparative examples of this specification. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0017] Hereinafter, an embodiment of the present specification will be described with reference to the accompanying drawings. However, the description of the present specification may be embodied in various different forms, and therefore is not limited to the embodiments described herein. In addition, in order to clearly describe an embodiment of the present specification in the drawings, parts that are not related to the description are omitted, and similar parts are designated by similar reference numerals throughout the specification.
[0018] Throughout the specification, when a part is said to be "connected" to another part, this includes not only "directly connected" but also "indirectly connected" via another element in between. Furthermore, when a part is said to "include" a certain component, this does not mean that it excludes the other component, but that it can further include the other component, unless otherwise specified.
[0019] When a range of numerical values is given herein, unless a specific range is specifically stated, the values have the precision of the significant figures provided in accordance with standard rules in chemistry for significant figures, for example, the number 10 includes a range of 5.0 to 14.9, and the number 10.0 includes a range of 9.50 to 10.49.
[0020] Hereinafter, an embodiment of the present specification will be described in detail with reference to the accompanying drawings.
[0021] Antibacterial dental implants According to one embodiment, there is provided a dental implant comprising a titanium substrate and a silver-titanium oxide matrix coated on at least a portion of a surface of the substrate, the silver-titanium oxide matrix having a peak P1 with binding energies of 570 to 580 eV and a peak P2 with binding energies of 360 to 375 eV as measured by XPS, and an intensity I1 of P1 and an intensity I2 of P2 satisfying the following formula:
[0022]
number
[0023] In order to increase the success rate of dental implants, a stable bond with the surrounding bone must be formed during the initial implantation period. Among the various causes of implant failure, early implant failure due to bacterial infection accounts for a large proportion.
[0024] The dental implant of the present specification may have antibacterial properties, including a titanium substrate and a silver-titanium oxide matrix coated on at least a portion of the surface of the substrate. The silver-titanium oxide matrix may block quorum sensing to inhibit the formation of a biofilm on the surface of the implant, thereby minimizing implant failure due to bacterial infection.
[0025] The term "quorum sensing" as used herein refers to a bacterial density-dependent gene expression regulation mechanism that accumulates in proportion to cell density during bacterial growth and regulates the collective metabolic activity of bacteria when a certain concentration is reached. In other words, it refers to a phenomenon in which, when the bacterial cell concentration reaches a so-called quorum for decision-making due to growth, a specific trait that is not observed in low-density cells is collectively induced and expressed. In particular, in the case of pathogenic bacteria, quorum sensing can induce virulence and cause infection.
[0026] The silver-titanium oxide matrix can release antibacterial silver ions to kill bacteria. As a result, the adhesion of bacteria to the surface of the implant can be suppressed. The silver ions can bind to cysteine groups in bacterial membranes to inactivate proteins. They can induce the release of reactive oxygen species from bound cells to kill bacteria. Silver ions can kill bacteria through the above-mentioned mechanism, effectively suppress the formation of biofilms, and maintain antibacterial properties persistently without antibacterial resistance.
[0027] The silver-titanium oxide matrix may contain antibacterial components in various forms, so that it has a necessary level of antibacterial activity at the initial stage of implantation and can maintain the antibacterial effect for a long period of time.
[0028] Peaks P1 and I1 at binding energies of 570-580 eV refer to the range of the Ag2p peak and its intensity value. Peaks P2 and I2 at 360-375 eV refer to the range of the Ag3d peak and its intensity value. The Ag2p refers to silver metal, and Ag3d refers to oxidized silver ions. A silver-titanium oxide matrix in which the intensities I1 and I2 at these peaks meet certain conditions can simultaneously contain silver metal and silver ions and realize a sustained release effect. In addition, if I1 and I2 meet certain conditions, the early implantation success rate of the dental implant can be effectively increased.
[0029] The terms I1 and I2 in the above formula refer to the ratio of silver metal to silver ions measured in the XPS graph. The I2 may be 2 times or more and 5 times or less than I1. In one example, the I2 may be 2 times or more, 2.1 times or more, 2.2 times or more, 2.3 times or more, 2.4 times or more, 2.5 times or more, 2.6 times or more, 2.7 times or more, 2.8 times or more, 2.9 times or more, 3 times or more, 3.1 times or more, 3.2 times or more, 3.3 times or more, or 3.4 times or more than I1. In another example, the I2 may be 5 times or less, 4.9 times or less, 4.8 times or less, 4.7 times or less, 4.6 times or less, 4.5 times or less, 4.4 times or less, 4.3 times or less, 4.2 times or less, 4.1 times or less, 4 times or less, 3.9 times or less, 3.8 times or less, 3.7 times or less, or 3.6 times or less than I1.
[0030] A dental implant that satisfies the above conditions can have an antibacterial effect such as killing bacteria and inhibiting adhesion during the initial implantation period due to a high initial silver release amount. In addition, the antibacterial effect can be sustained by having a sustained release effect in which silver is gradually released.
[0031] For example, the dental implant may release 1 ppm / day or less of silver for at least one week in an inorganic solvent at 37°C. The sustained release effect of the dental implant may last for at least one week, one month, two months, three months or more. The sustained release effect of the dental implant means realizing a sustained antibacterial effect by releasing at least one of silver ions and silver metal for a long period of time. The inorganic solvent means water such as purified water, ion-exchanged water, etc. The dental implant may release at least 1 ppb / day or more, 5 ppb / day or more, or 10 ppb / day or more of silver during the period.
[0032] As a non-limiting example, the titanium substrate refers to a material made of pure titanium or an alloy of titanium and other metals on the periodic table, and the titanium alloy may be, but is not limited to, one selected from the group consisting of titanium (Ti) and aluminum (Al), silicon (Si), vanadium (V), niobium (Nb), zirconium (Zr), molybdenum (Mo), chromium (Cr), tin (Sn), tantalum (Ta), palladium (Pd), and combinations of at least one of these.
[0033] Antibacterial coating method for dental implants According to another aspect, there is provided a method for antibacterial coating of a dental implant, comprising the steps of (a) supporting a titanium substrate in a coating solution in which a silver precursor is dissolved to have an Ag concentration of 10 to 300 mM, and (b) heating the coating solution to perform a hydrothermal treatment.
[0034] In the step (a), the titanium substrate may be supported in a coating solution in which a silver precursor is dissolved. The silver precursor may be, but is not limited to, one selected from the group consisting of silver nitrate (AgNO3), silver perchlorate (AgClO4), silver tetrafluoroborate (AgBF4), silver hexafluorophosphate (AgPF6), silver acetate (CH3COOAg), silver trifluoromethanesulfonate (AgCF3SO3), silver sulfate (Ag2SO4), silver 2,4-pentanedionate (CH3COCH=COCH3Ag), silver oxides (AgO, Ag2O, Ag2O2, Ag2O3), and mixtures of two or more thereof.
[0035] For example, the Ag concentration of the coating solution may be 10 to 300 mM. 0mM, 41mM, 42mM, 43mM, 44mM, 45mM, 46mM, 47mM, 48mM, 49mM, 50mM, 51mM, 52mM, 53mM, 54mM, 55m M, 56mM, 57mM, 58mM, 59mM, 60mM, 61mM, 62mM, 63mM, 64mM, 65mM, 66mM, 67mM, 68mM, 69mM, 70mM, 7 1mM, 72mM, 73mM, 74mM, 75mM, 76mM, 77mM, 78mM, 79mM, 80mM, 81mM, 82mM, 83mM, 84mM, 85mM, 86m M, 87mM, 88mM, 89mM, 90mM, 91mM, 92mM, 93mM, 94mM, 95mM, 96mM, 97mM, 98mM, 99mM, 100mM, 110mM , 120 mM, 130 mM, 140 mM, 150 mM, 160 mM, 170 mM, 180 mM, 190 mM, 200 mM, 210 mM, 220 mM, 230 mM, 240 mM, 250 mM, 260 mM, 270 mM, 280 mM, 290 mM, 300 mM, or a range between two of these values, but is not limited thereto. If the Ag concentration is below this range, the amount of silver may be insufficient, resulting in a decrease in antibacterial properties, and if it exceeds this range, it may be difficult to form a coating solution or the formation of a coating layer may be poor due to problems such as viscosity.
[0036] As an example, the method may further include a pretreatment step of treating the titanium substrate by at least one of sandblasting, etching, cleaning, and drying before carrying out the step (a). This is not limited to the above.
[0037] If the titanium substrate is sandblasted or etched to impart surface roughness, the bone fusion properties can be improved, but the adhesion to bacteria can also increase. The titanium substrate can be washed or dried to remove foreign matter on the surface of the substrate, and the subsequent antibacterial coating layer can be effectively formed.
[0038] In the step (b), the coating solution may be heated and hydrothermally treated to form a silver-titanium oxide matrix on the surface of the titanium substrate.
[0039] In one example, the step (b) may be performed under conditions of 150 to 300°C and 1 to 5 hours. The step (b) may be performed at a temperature of, for example, 150°C, 155°C, 160°C, 165°C, 170°C, 175°C, 180°C, 185°C, 190°C, 195°C, 200°C, 205°C, 210°C, 215°C, 220°C, 225°C, 230°C, 235°C, 240°C, 245°C, 250°C, 255°C, 260°C, 265°C, 270°C, 275°C, 280°C, 285°C, 290°C, 295°C, 300°C, or a range between two of these values, but is not limited thereto. The temperature condition of the step (b) may affect the amount of silver coating of the silver-titanium oxide matrix and the antibacterial performance thereof. Furthermore, step b) may be carried out for a period of time, for example, 1 hour, 1.5 hours, 2 hours, 2.5 hours, 3 hours, 3.5 hours, 4 hours, 4.5 hours, 5 hours, or a range between any two of these values, but is not limited thereto.
[0040] After step (b), the surface of the titanium substrate may be washed to remove unbound silver ions. However, such washing may be performed in a manner that does not inhibit the antibacterial activity of the silver-titanium oxide matrix formed on the surface of the titanium substrate. For example, washing may be performed by immersing the titanium substrate in one selected from the group consisting of purified water, alcohol, and mixtures thereof, followed by stirring.
[0041] The examples of the present specification will be described in more detail below. However, the following experimental results are only representative experimental results among the above examples, and the scope and content of the present specification should not be construed as being narrowed or limited by the examples. The respective effects of various embodiments of the present specification that are not explicitly presented below will be specifically described in the corresponding parts.
[0042] Experimental example 1: Selection of antibacterial ions To select antibacterial ions, the saliva bacterial contamination rate was evaluated. 100ml of saliva (SA) was prepared as the control group, and 100ml of saline, hydration solution (EC), magnesium ion salt, and silver ion salt were prepared as the experimental group. 1ml of saliva bacterial suspension isolated from the prepared saliva was added to each solution for the control and experimental groups, and then maintained at 37°C under anaerobic conditions for 16 hours. After 16 hours, the saliva bacterial contamination rate was measured, and the results are shown in Figure 1. The saliva bacterial contamination rate of the control saliva was set to 100%, and the saliva bacterial contamination rate of the experimental group was measured.
[0043] Referring to Figure 1, saline and hydration solution (EC) showed saliva bacterial contamination rates of 52.45% and 23.6%, respectively, compared to saliva. Magnesium ion salt, an antibacterial ion salt, showed the highest saliva bacterial contamination rate of 102.34%. In contrast, silver ion salt showed a saliva bacterial contamination rate of 0.28%, showing a bacterial contamination reduction rate of 99.7% compared to saliva. Therefore, silver ions were selected as the antibacterial ion.
[0044] Experimental example 2: Selection of antibacterial coating method Animal experiments were conducted to select an antibacterial coating method. Titanium implants were prepared as a control group. Titanium implants treated with a solution containing silver ion salt and hydrogen peroxide and titanium implants hydrothermally treated with a solution containing silver ion salt were prepared as experimental groups. Eight implant samples were prepared for each group. The prepared implants were contaminated by exposing them to saliva for 24 hours before implantation, and then implanted into the tibia of rabbits and maintained for 21 days to allow bone formation, after which the removal torque was evaluated. The experimental results are shown in Figure 2.
[0045] Referring to FIG. 2, FIG. 2(a) shows the average value of the removal torque for each of the eight samples. FIG. 2(b) shows the removal torque for each of the eight samples. In the case of untreated titanium implants, the average removal torque was 26.95N, indicating the poorest result, and two out of eight cases of implantation failure were recorded. In contrast, the silver ion-coated implants showed values of 46.43N and 52.11N, respectively, confirming that saliva contamination by silver ions was reduced. In addition, the implants coated with silver ions by hydrothermal treatment showed the best removal torque, and zero out of eight cases of implantation failure were recorded. Therefore, the excellent antibacterial properties of silver ions against salivary bacteria were confirmed, and hydrothermal treatment was selected as the coating method.
[0046] Experimental Example 3: Selection of hydrothermal treatment conditions 1 To select the hydrothermal treatment conditions, the antibacterial performance was evaluated according to temperature, time and silver ion concentration.
[0047] For the evaluation, the titanium substrate was cut into 3 × 3 cm pieces. 2 Nine samples of different sizes were prepared. The hydrothermal treatment conditions for each titanium substrate were 180°C, 200°C, and 250°C for 1 hour, 2 hours, and 3 hours, and the silver ion concentrations were 30 mM, 60 mM, and 100 mM.
[0048] Aggregatilacter actinomycetemcomitans ATCC 33384 and Porphyromonas gingivalis, causative bacteria of acute periodontitis and peri-implantitis, were used as salivary bacteria. The prepared salivary bacteria were inoculated into BHI (Brain heart infusion broth, Merck) medium and cultured for 16 to 24 hours under anaerobic conditions at 37°C. The culture solution was diluted with BHI medium to a 600 nm absorbance of 0.1, and then further diluted once with BHI medium to a bacterial concentration of 1 / 10 to prepare two types of salivary bacterial suspensions.
[0049] The nine titanium substrates were sterilized by exposing them to UV light on a clean bench for 30 minutes, and then placed one per well in a 24-well plate. 1 mL of the prepared saliva bacterial suspension was placed in each well and cultured at 37°C under anaerobic conditions for 16 hours. 1 mL of 0.1 wt% crystal violet solution was placed in each well of a new 24-well plate. The samples were transferred to each well of the well plate containing crystal violet, and incubated at room temperature for 10 minutes to stain the bacteria purple.
[0050] A new 24-well plate was prepared by adding 1 mL of phosphate buffered saline (PBS) solution to each well, and each stained sample was transferred to each well, and the above process was repeated. The samples washed with PBS were transferred onto a dry tissue and the bottom of the sample was wiped. A new 24-well plate was added with 500 μL of 30 wt% acetic acid solution to each well, and each sample was transferred to each well and incubated at room temperature for 20 minutes to dissolve the dye. 200 μL of the dissolved solution was added to a 96-well plate, and the absorbance (595 nm) was measured using a microplate reader, and the results are shown in Figure 3. For comparison with the samples, the absorbance (OD, 595 nm) was measured for media not inoculated with salivary bacteria and untreated titanium substrate samples, along with the control group treated with salivary bacteria suspension as described above.
[0051] The hydrothermal treatment conditions for each of the nine samples are shown in Table 1 below.
[0052] [Table 1]
[0053] Referring to Table 1 and FIG. 3, all samples except for samples 1 and 4 showed OD (595 nm) values of 0.08 or less, confirming that silver ions have an excellent effect of inhibiting salivary bacteria.
[0054] To determine the optimal hydrothermal treatment conditions, the OD (595 nm) values for each temperature, time, and silver ion concentration were added together and shown in Table 2.
[0055] [Table 2]
[0056] Referring to Table 2, the OD (595 nm) values according to temperature conditions in the hydrothermal treatment were 0.246 and 0.212 at 200°C and 250°C, respectively, and it was confirmed that the antibacterial properties were improved compared to the case of hydrothermal treatment at 180°C. In addition, the saliva bacterial contamination rate according to time conditions was excellent at 2 hours and 3 hours, and the saliva bacterial contamination rate according to silver ion concentration was excellent at 60 mM and 100 mM. Therefore, the optimal hydrothermal treatment conditions for improving antibacterial properties were derived to be a temperature of 200 to 250°C, a time of 2 to 3 hours, and a silver ion concentration of 60 to 100 mM.
[0057] Experimental Example 4: Selection of hydrothermal treatment conditions 2 In order to select the hydrothermal treatment conditions, the H2O2 concentration (chemical treatment), temperature, the inhibition rate of saliva bacterial contamination over time, the initial amount of titanium (Ti) ions eluted, and the amount of silver (Ag) ions released were evaluated during the hydrothermal treatment.
[0058] For the evaluation, the titanium substrate was cut into 3 × 3 cm pieces. 2 Nine samples of different sizes were prepared. The hydrothermal treatment conditions for each titanium substrate were H2O2 concentration of 0 wt% (no addition), 1 wt%, and 2 wt%, temperature of 180°C, 200°C, and 250°C, time of 1 hour, 2 hours, and 3 hours, and silver ion concentration was fixed at 100 mM.
[0059] The inhibition rate of salivary bacterial contamination was determined in the same manner as in the antibacterial performance evaluation described above in Experimental Example 3, and the inhibition rate of salivary bacterial contamination was calculated based on the OD (595 nm) value of an untreated titanium substrate sample contaminated with salivary bacteria.
[0060]
number
[0061] To derive the optimal hydrothermal treatment conditions, the combined values of the inhibition rate of saliva bacterial contamination, initial Ti elution amount, and Ag release amount for each H2O2 concentration, temperature, and time are shown in Table 3.
[0062] [Table 3]
[0063] Referring to Table 3, the inhibition rate of saliva bacterial contamination according to the H2O2 concentration conditions in hydrothermal treatment showed a slight difference of 0.08 between the maximum and minimum values, but it was confirmed that the higher the concentration, the greater the increase in the initial Ti elution amount. Therefore, H2O2 was not used during hydrothermal treatment. In addition, the temperature condition showed excellent Ag ion release amount at 200°C or higher, and the initial Ti ion elution was small, showing a significant result. The inhibition rate of saliva bacterial contamination according to time condition showed the highest inhibition rate at 3 hours, the release amount of Ag ions showed the highest elution amount at 2 hours, and the initial Ti ion elution amount was the smallest at 3 hours.
[0064] Examples and Comparative Examples were prepared according to the selection of antibacterial ions and hydrothermal treatment conditions in Experimental Examples 1 to 4 described above.
[0065] Working Example A disk (cylinder)-shaped Cp-Ti (Titanium Grade 4) specimen with a diameter of 6 mm, thickness of 2 mm, and length of 10 mm was prepared. The specimen was then placed in a silver nitrate solution with an Ag concentration of 100 mM, and then heated and hydrothermally treated at a temperature of 200°C for 3 hours. After the hydrothermal treatment, the specimen was placed in deionized water for 5 minutes and washed to complete the antibacterial coating on the specimen.
[0066] Comparative Example 1 The same procedure as in Example 1 was carried out except that the silver precursor solution was replaced with purified water and the hydrothermal treatment was carried out.
[0067] Comparative Example 2 The same procedure as in the Example was carried out, except that after the hydrothermal treatment, the substrate was placed in purified water and subjected to ultrasonic cleaning for 5 minutes.
[0068] Experimental Example 5: FE-SEM and EDS analysis For surface analysis of the examples and comparative examples, FE-SEM and EDS analysis were performed, and the results are shown in FIGS. 4 is an FE-SEM analysis image of the Examples and Comparative Examples of the present specification. Referring to FIG. 4, it can be seen that silver particles are formed on the surface of the Examples. In contrast, it can be seen that no coating particles are formed on the surface of Comparative Example 1, and that the coating of silver particles is reduced in Comparative Example 2 compared to the Examples.
[0069] Figure 5 shows the element distribution of titanium and silver by position in the SEM image of the embodiment. Referring to Figure 5, titanium 99.79 at% and silver 0.21 at% are shown at position 1, titanium 99.69 at% and silver 0.31 at% are shown at position 2, and titanium 94.16 at% and silver 5.84 at% are shown at position 3. It can be seen that bulk silver particles are formed at position 3, increasing the silver at%.
[0070] Figure 6 shows EDS analysis images of the examples and comparative examples of the present specification. Referring to Figure 6, it can be seen that silver is uniformly distributed on the surface of the titanium substrate in the examples. It can be seen that in the comparative example 1, no antibacterial coating layer is formed and only titanium element is distributed. It can be seen that in the comparative example 2, silver is uniformly distributed on the surface of the titanium substrate, but in a smaller amount than in the examples.
[0071] Experimental Example 6: XPS Analysis XPS analysis was performed to analyze the atomic state of the examples and comparative examples, and the results are shown in Figure 7. As a control, an untreated Cp-Ti (Titanium Grade 4) specimen was also subjected to XPS analysis.
[0072] Referring to Figure 7, it can be seen that the peaks of Ag metal (Ag2p) and oxidized Ag ions (Ag3d) were detected simultaneously in the analysis graph of the example. This confirms that the example effectively coats the surface of the titanium substrate with silver particles. In contrast, no peaks for Ag were detected in the comparative example, and only peaks for Ti (Ti2s, Ti2p) were detected. The control group shows a peak appearance similar to that of the comparative example, but it can be seen that the oxidized Ti ion peak appears weakly because the surface treatment was not performed.
[0073] Comparing the heights of the Ag metal peak and the oxidized Ag ion peak, it can be seen that the Ag3d peak at 360-375 eV is approximately 3.5 times higher than the Ag2p peak at 570-580 eV.
[0074] Experimental Example 7: Evaluation of Ag release amount In order to evaluate the amount of Ag released depending on the loading period of the embodiment, the specimen of the embodiment was loaded in purified water (DW) and the amount of Ag released was measured for 90 days. The amount of Ag released was measured using an ICP-MS analyzer, and the results are shown in Figure 8.
[0075] Referring to FIG. 8, the Ag ion release amount was 250 ppb or more immediately after loading, and 100 ppb or more after 3 days from loading. It can be confirmed that the Ag ion release amount gradually decreases after 3 days from loading, and 50 ppb or more of Ag ions are slowly released after 30 days. The Ag ion release amount was 30 ppb or more after 60 days from loading. Therefore, when the examples of this specification are applied to dental implants, it can be predicted that antibacterial silver ions are slowly released during the initial implantation period (about 3 months), and the initial implantation failure rate is significantly reduced.
[0076] Experimental Example 8: Antibacterial performance evaluation based on Ag ion release period The antibacterial performance of the embodiment was evaluated according to the Ag ion release period. For comparison with the embodiment, the inhibition rate of salivary bacterial contamination was measured for a medium not inoculated with salivary bacteria (Media) and a medium containing only a salivary bacterial suspension (Control group), and the results are shown in Figure 9.
[0077] 9, the saliva bacterial contamination inhibition rate was 80% or more on the third day according to the Ag ion release period of the embodiment. Over the course of 90 days, the saliva bacterial contamination inhibition rate gradually decreased, but still showed 60% or more of saliva bacterial contamination inhibition rate. This confirms that Ag ions are gradually released within 90 days.
[0078] Experimental Example 9: Antibacterial performance evaluation according to cleaning conditions Antibacterial performance evaluation was performed under Ag cleaning conditions in the examples and comparative examples. For evaluation, the examples and comparative example 2, which were ultrasonically cleaned with purified water after hydrothermal treatment, were selected. In comparative example 2, the ultrasonic cleaning time was divided into 1 minute, 3 minutes, and 5 minutes according to the cleaning time, and set as comparative examples 2-1, 2-2, and 2-3, respectively. Comparative example 3 was set by replacing the cleaning solution with ethanol, and the ultrasonic cleaning time was divided into 1 minute, 3 minutes, and 5 minutes, and set as comparative examples 3-1, 3-2, and 3-3, respectively. Antibacterial performance evaluation was performed as described above in experimental example 3, and the OD (595 nm) value, which is the absorbance, was measured, and the results are shown in FIG. 10.
[0079] Referring to Figure 10, it was shown that the antibacterial properties of the examples in which the sample was supported in purified water and washed were the best. In contrast, Comparative Examples 2 (2-1, 2-2, 2-3) and 3 (3-1, 3-2, 3-3), which were subjected to ultrasonic washing, showed a slight decrease in antibacterial properties. This is expected because some of the bulk ion particles are removed by ultrasonic washing, which affects the antibacterial properties. It was confirmed that the washing solution had almost no effect on the antibacterial properties.
[0080] The above description of the present specification is for illustrative purposes only, and a person having ordinary skill in the art to which one embodiment of the present specification belongs can easily understand that the present specification can be easily modified into other specific forms without changing the technical ideas and essential features described in the present specification. Therefore, the above-described embodiment should be understood to be illustrative in all respects and not limiting. For example, each component described in a single form may be implemented in a distributed form, and similarly, each component described as being distributed may be implemented in a combined form.
[0081] The scope of this specification is defined by the claims below, and all modifications and variations derived from the meaning and scope of the claims and their equivalent concepts should be construed as being included in the scope of this specification.
Claims
1. Titanium substrate, and a silver-titanium oxide matrix coated on at least a portion of a surface of the substrate; The silver-titanium oxide matrix has a peak P 1 and peak P of 360 to 375 eV 2 having P 1 Strength I 1 and P 2 Strength I 2 is a dental implant that satisfies the following formula: [0010]
2. 10. The dental implant of claim 1, wherein the dental implant releases less than or equal to 1 ppm silver per day for at least one week in an inorganic solvent at 37°C.
3. (a) supporting a titanium substrate in a coating solution in which a silver precursor is dissolved to have an Ag concentration of 10 to 300 mM; and (b) a step of heating the coating solution to subject the solution to a hydrothermal treatment.
4. The silver precursor is silver nitrate (AgNO 3 ), silver perchlorate (AgClO 4 ), silver tetrafluoroborate (AgBF 4 ), silver hexafluorophosphate (AgPF 6 ), silver acetate (CH 3 COOAg), silver trifluoromethanesulfonate (AgCF 3 SO 3 ), silver sulfate (Ag 2 SO 4 ), Silver 2,4-pentanedionate (CH 3 COCH=COCH 3 Ag), silver oxides (AgO, Ag 2 O, Ag 2 O 2 , Ag 2 O 3 4. The method for antibacterial coating of dental implants according to claim 3, wherein the antibacterial agent is one selected from the group consisting of tetrahydrofuran, ...
5. 4. The method for antibacterial coating of dental implants according to claim 3, further comprising a pre-treatment step of treating the titanium substrate with at least one of sandblasting, etching, cleaning and drying before carrying out step (a).
6. 4. The method of claim 3, wherein step (b) is carried out at 150 to 300° C. for 1 to 5 hours.
Citation Information
Patent Citations
Antimicrobial artificial tooth root based on nanometer tube arrays and preparation method thereof
CN101766541A
A method for preparing silver-containing titanium dioxide film on the surface of medical titanium or titanium alloy
CN103877618B
Silver iodate compounds having antimicrobial properties
WO2012021979A1
